The Application of 18F-G1 PET/CT Targeting Granzyme B in the Pan-cancer Immunotherapy
NCT07039474 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 120
Last updated 2025-06-26
Summary
The purpose of this study is to explore the effectiveness of 18F-G1 PET/CT in patients with solid tumors and hematological malignancies receiving immunotherapy
Conditions
- Solid Tumors and Hematological Tumors
Interventions
- DRUG
-
18F-G1
18F-G1 is injected intravenously with a dose of 0.06-0.08mCi/kg
Sponsors & Collaborators
-
Peking University First Hospital
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2025-07-15
- Primary Completion
- 2026-12-31
- Completion
- 2027-06-01
More Related Trials
-
18F-FAPI PET/CT in Patients With Various Types of Cancer
NCT05810324 ·Status: UNKNOWN ·Phase: NA
-
Fluoroglutamine PET/CT in Imaging Patients With Malignant Tumor
NCT03721055 ·Status: UNKNOWN ·Phase: NA
-
The Value of PET Imaging Targeting Granzyme B in Predicting Efficacy and Prognosis in T-NK Cell Lymphoma
NCT06863441 ·Status: NOT_YET_RECRUITING
-
A Study Evaluating the Value of 68Ga-Pentixafor PET Imaging in the Staging of Hematological Tumor, and Comparing It with 18F-FDG PET/CT Imaging
NCT06834412 ·Status: RECRUITING ·Phase: NA
-
First Human Trial of Targeting MDM2/MDMX PET Imaging
NCT06443762 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
TF-antigen Targeting Molecular Probe for PET Imaging in Solid Tumors
NCT06755086 ·Status: NOT_YET_RECRUITING
-
18F-AlF-FAPi-04 PET/CT Imaging in Patients With Solid Tumor
NCT06126705 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Evaluating the Usefulness of 18F-AlF-FAPI PET/ CT in Orbital Neoplasms
NCT06791226 ·Status: RECRUITING ·Phase: NA
-
Head-to-head Comparison Between [18F]-FDG PET/CT and PET/MRI in Lymphomas
NCT05390632 ·Status: UNKNOWN
-
18F-FAPI-04 PET/CT and PET/MR in Patients With Various Types of Malignant Tumors
NCT06557590 ·Status: RECRUITING
-
Tracer Targeting FAP PET Imaging in Patients
NCT05691894 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
First in Human Study of 68Ga/64Cu-FAPI-XT117 PET/CT in Patients With Malignant Solid Tumors
NCT05814835 ·Status: COMPLETED ·Phase: PHASE1
-
Positron Nuclide Labeled NOTA-FAPI PET Study in Lymphoma
NCT04367948 ·Status: UNKNOWN ·Phase: NA
-
68Ga-FAPI-RGD PET/CT for Dual Integrin αvβ3 and FAP-targeted Imaging in Patients With Various Types of Cancer and Compared With 18F-FDG
NCT05543317 ·Status: COMPLETED ·Phase: NA
-
18F-FAPI-RGD PET/CT in Various Tumor Types
NCT06094530 ·Status: RECRUITING
-
Study of 64Cu-FAPI-XT117 PET/CT in Patients With Malignant Solid Tumors
NCT05930457 ·Status: COMPLETED ·Phase: PHASE1
-
18F-mFBG PET Imaging in the Evaluation of Pheochromocytoma
NCT06813742 ·Status: RECRUITING
-
68Ga-NYM096 PET/CT in Various Kinds of Cancer
NCT07144748 ·Status: RECRUITING ·Phase: NA
-
Granzyme B-targeted PET Imaging Monitoring Tumor Responses to Immunotherapy
NCT06916442 ·Status: NOT_YET_RECRUITING
-
18F-Labeled Picolinamide PET Imaging of Melanoma Diagnosis
NCT03033485 ·Status: UNKNOWN ·Phase: NA
-
Perfusion and Hypoxia Evaluation in Tumors Using 18F-FDG PET/CT
NCT03373994 ·Status: UNKNOWN
-
To Compare the Clinical Application of 18F-LNC1007 Injection PET/CT and 18F-FDG PET/CT
NCT06205888 ·Status: NOT_YET_RECRUITING
-
18F-FDG PET/CT-based Prognostic Model for Predicting Outcome in Patients With Peripheral T-cell Lymphoma
NCT03051581 ·Status: UNKNOWN ·Phase: NA
-
68Ga-TCR-FAPI PET/CT in Patients With Various Types of Cancer
NCT06084767 ·Status: RECRUITING ·Phase: NA
-
CD70-targeted immunoPET Imaging of Malignant Cancers
NCT06852638 ·Status: RECRUITING ·Phase: PHASE2